Jan Münch

Researcher Next ID · RN-026990

Researcher · Immunology and Microbiology

Ulm, Slovakia

Not currently recruitingFunding unknown

Research interests

Immunology and Microbiology

Medicine

HIV Research and Treatment

SARS-CoV-2 and COVID-19 Research

COVID-19 Clinical Research Studies

HIV/AIDS drug development and treatment

Immunotherapy and Immune Responses

Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2
Nature Immunology · 2024 · https://doi.org/10.1038/s41590-023-01724-6
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.03.036
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
Nature Communications · 2021 · https://doi.org/10.1038/s41467-021-24817-y
Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses
Nature Nanotechnology · 2013 · https://doi.org/10.1038/nnano.2012.248
Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains
Cell Host & Microbe · 2009 · https://doi.org/10.1016/j.chom.2009.10.004

No projects listed.